Digital Health Japan

Japan AI in Pathology Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Japan AI in Pathology Market Industry Trends and Forecast to 2034: Segmented by (Application, Component, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $18.1 Mn Placeholder estimate
Estimate 2025 $23.4 Mn 7.1% of the global market
Projected 2034 $226.2 Mn 868.7% Adds $202.9 Mn over 9 forecast years
CAGR 2025–2034 28.7% Faster than 89% of 100 Digital Health markets here
Key players 6 +1
  • Japan is 7.13% of the global market.
  • In APAC, the largest is China at $30.9 Mn.
  • Fastest growing: India at 30.6% a year.
  • Japan ranks 2nd of 10 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$202.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
AI in Pathology Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $18.1 Mn — —
2025 (base) $23.4 Mn +$5.2 Mn —
2026 (forecast) $30.1 Mn +$6.7 Mn +28.7%
2027 (forecast) $38.7 Mn +$8.6 Mn +65.6%
2028 (forecast) $49.8 Mn +$11.1 Mn +113.2%
2029 (forecast) $64.1 Mn +$14.3 Mn +174.4%
2030 (forecast) $82.5 Mn +$18.4 Mn +253.1%
2031 (forecast) $106.1 Mn +$23.7 Mn +354.4%
2032 (forecast) $136.6 Mn +$30.5 Mn +484.9%
2033 (forecast) $175.8 Mn +$39.2 Mn +652.7%
2034 (forecast) $226.2 Mn +$50.5 Mn +868.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan AI in Pathology Market Analysis at a glance
Market size, 2025$23.4 Mn placeholder estimate
Forecast, 2034$226.2 Mn placeholder estimate
Growth (CAGR), 2025–203428.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication, component and end user (see all)
Key playersPaige, PathAI, Ibex Medical Analytics, Philips Healthcare, Roche and 1 more (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan AI in Pathology Market Analysis Executive Summary

AI in pathology analyses digital images of tissue slides to help pathologists find cancer and other diseases faster and more consistently.

Key segments of the AI in Pathology market include application (Cancer Detection, Grading and Biomarker Scoring) and component (Software and Services).

Bar chart: Japan AI in Pathology market size, 2024–2034, placeholder estimates. $18.1 Mn in 2024, $23.4 Mn in 2025 and $226.2 Mn in 2034, 28.7% CAGR.
Japan AI in Pathology market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan AI in Pathology Market Dynamics

Market Growth Drivers

Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI in Pathology market. Health systems are moving from pilots to wider use.

Opportunity

Generative AI, automation of paperwork and AI tools approved as medical devices give the AI in Pathology market strong growth, including in emerging health systems.

Market Restraints

Concerns about accuracy, bias, privacy and liability, along with unclear regulation and the cost of fitting AI into clinical workflows, hold back the AI in Pathology market.

Competitive Landscape for AI in Pathology Market in Japan

The AI in Pathology market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for AI in Pathology Market in Japan

AI in Pathology in Japan: rules and payment

Software can be approved as a medical device (a programmed medical device), with review by the Pharmaceuticals and Medical Devices Agency (PMDA).⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2]

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the AI in Pathology market. Government digital health programs in Japan are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in AI in Pathology right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

AI in Pathology in context

Japan compared

  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 30.0% of people (2025). World: 10.4% of people (2025). Highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Inside Japan

Quick answers

Frequently asked questions

How big is the AI in Pathology market in Japan?
Placeholder estimate: about $23.4 Mn in 2025, rising to about $226.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the AI in Pathology market in Japan growing?
Placeholder estimate: about 28.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the AI in Pathology market report cover?
The report splits the market by application (Cancer Detection, Grading, Biomarker Scoring, Workflow Triage), component (Software, Services) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the AI in Pathology market?
Key players include Paige, PathAI, Ibex Medical Analytics, Philips Healthcare, Roche and Proscia.
What is driving the AI in Pathology market?
Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI in Pathology market. Health systems are moving from pilots to wider use.
Who regulates AI in Pathology in Japan?
Software can be approved as a medical device (a programmed medical device), with review by the Pharmaceuticals and Medical Devices Agency (PMDA). Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
How much research is published on AI in Pathology?
PubMed lists 55 papers on AI in Pathology added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in Japan

See all

Related on artificial intelligence and diagnostics and lab testing

See the topic